Clinical trials
Active, not recruiting Sarcoma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 6 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 5 |
| USWM CT, LLC | 2 |
| University of Calgary | 2 |
| Actuate Therapeutics Inc. | 1 |
| Cellectar Biosciences, Inc. | 1 |
| Eli Lilly and Company | 1 |
| Hoffmann-La Roche | 1 |
| McMaster University | 1 |
| Mount Sinai Hospital, Canada | 1 |
| National Cancer Institute LAO | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma | 17 |
| Glioma | 5 |
| Central Nervous System Neoplasms | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Medulloblastoma | 4 |
| Neoplasm Metastasis | 4 |
| Neuroblastoma | 4 |
| Rhabdoid Tumor | 4 |
| Wilms Tumor | 4 |
| Ependymoma | 3 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.